Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Altergon SA v. Actavis Labs. UT, Inc., 15-0883 (D. Del.) Oct. 1, 2015 Hon. Richard G. Andrews Flector® (diclofenac epolamine patch) 5,607,690
Alcon Pharms. Ltd. v. Par Pharm., Inc., 15-7240 (D.N.J.) Oct. 1, 2015 Hon. Peter G. Sheridan Ciprodex® (ciprofloxacin / dexamethasone otic suspension)
6,284,804
6,359,016
Amerigen Pharms. Ltd. v. Shire LLC, IPR2015-02009 (PTAB) Oct. 1, 2015 N/A Adderall XR® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) RE42,096
Steadymed Ltd. v. United Therapeutics Corp., IPR2016-00006 (PTAB) Oct. 2, 2015 N/A
Remodulin® (treprostinil for injection)
Tyvaso® (treprostinil solution)
Orenitram® (treprostinil diolamine extended-release tablets)
8,497,393
Actavis Labs. UT, Inc. v. Par Pharm., Inc., 15-0886 (D. Del.) Oct. 2, 2015 Hon. Leonard P. Stark Gelnique® (oxybutynin chloride gel)
7,029,694
7,179,483
8,241,662
8,920,392
AbbVie Inc. v. Hetero USA Inc., 15-0889 (D. Del.) Oct. 2, 2015 Hon. Richard G. Andrews Kaletra® (lopinavir / ritonavir tablets)
6,037,157
6,703,403
7,148,359
7,364,752
8,025,899
8,268,349
8,399,015
8,309,613
8,377,952
8,470,347
8,691,878
Lupin Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01881 (PTAB) Oct. 5, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,569,325
Lupin Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01882 (PTAB) Oct. 5, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,404,703
Par Pharm., Inc. v. Jazz Pharms., Inc., IPR2016-00002 (PTAB) Oct. 6, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,772,306
Ranbaxy Inc. v. Jazz Pharms., Inc., IPR2016-00024 (PTAB) Oct. 7, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,772,306
Merck & CIE v. Lupin Ltd., 15-0899 (D. Del.) Oct. 8, 2015 Hon. Richard G. Andrews Beyaz® (drospirenone / 17α-ethinylestradiol / levomefolate calcium tablets) 6,441,168
Salix Pharms., Inc. v. Taro Pharms. USA, Inc., 15-0900 (D. Del.) Oct. 8, 2015 Hon. Sue L. Robinson Moviprep® (ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate oral solution)
7,169,381
7,658,914
Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-7378 (D.N.J.) Oct. 8, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,518,981
8,598,218
9,066,980
9,125,905
Bayer Intellectual Property GmbH v. Aurobindo Pharma Ltd., 15-0902 (D. Del.) Oct. 9, 2015 Hon. Sue L. Robinson Xarelto® (rivaroxaban tablets)
7,157,456
7,585,860
7,592,339
Forest Labs., LLC v. Accord Healthcare, Inc., 15-0903 (D. Del.) Oct. 9, 2015 Hon. Leonard P. Stark Namenda® XR (memantine hydrochloride extended-release tablets)
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233
Unimed Pharms., LLC v. Lupin Atlantis Holdings SA, 15-0904 (D. Del.) Oct. 9, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,466,136
8,466,137
8,466,138
8,486,925
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-0908 (D. Del.) Oct. 9, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
AstraZeneca AB v. Teva Pharms. USA, Inc., 15-0909 (D. Del.) Oct. 9, 2015 Hon. Gregory M. Sleet Kombiglyze™ XR (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets) 8,628,799
AstraZeneca AB v. Zydus Pharms. (USA) Inc., 15-7415 (D.N.J.) Oct. 9, 2015 Hon. Mary L. Cooper Nexium® (esomeprazole magnesium delayed-release tablets)
6,369,085
7,411,070
8,466,175
Salix Pharms., Inc. v. Taro Pharms. USA, Inc., 15-7980 (S.D.N.Y.) Oct. 9, 2015 Hon. Vernon S. Broderick Moviprep® (ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate oral solution)
7,169,381
7,658,914
Flamel Ireland, Ltd. v. Mylan Pharms. Inc., 15-0178 (N.D.W.V.) Oct. 9, 2015 Hon. Irene M. Keeley Coreg CR® (carvedilol phosphate extended-release capsules) 8,101,209
Agila Specialties Inc. f/k/a Strides Inc. v. Cephalon, Inc., IPR2016-00026 (PTAB) Oct. 9, 2015 N/A Treanda® (bendamustine hydrochloride for infusion) 8,791,270
Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-0918 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,518,981
8,598,218
9,066,980
9,125,905
Vanda Pharms. Inc. v. Roxane Labs., Inc., 15-0919 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets) 9,138,432
Vanda Pharms. Inc. v. Taro Pharms. USA, Inc., 15-0920 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets)
8,586,610
9,138,432
Vanda Pharms. Inc. v. Inventia Healthcare Pvt. Ltd., 15-0921 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets) 9,138,432
Vanda Pharms. Inc. v. Apotex Inc., 15-0922 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets)
8,586,610
9,138,432
Boehringer Ingelheim Pharma GmbH & Co. KG v. Sandoz Inc., 15-7461 (D.N.J.) Oct. 13, 2015 Hon. Noel L. Hillman Aggrenox® (dipyridamole / acetylsalicylic acid extended-release capsules) 6,015,577
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-2905 (S.D. Ohio) Oct. 13, 2015 Hon. Edmund A Sargus Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
AstraZeneca Pharms. LP v. Mylan Pharms. Inc., 15-0183 (N.D.W.V.) Oct. 15, 2015 Hon. Irene M. Keeley Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
Neptune Generics, LLC v. AstraZeneca PLC., IPR2016-00049 (PTAB) Oct. 15, 2015 N/A Movantik® (naloxegol oxalate tablets) 7,786,133
Purdue Pharma L.P. v. Alvogen Pine Brook, Inc., 15-0940 (D. Del.) Oct. 16, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,084,816
9,095,614
9,095,615
Fresenius Kabi USA, LLC v. Mylan Labs. Ltd., 15-0942 (D. Del.) Oct. 19, 2015 Hon. Leonard P. Stark Naropin® (ropivacaine hydrochloride for injection)
7,828,787
7,857,802
8,118,802
8,162,915
Jazz Pharms., Inc. v. Par Pharm., Inc., 15-7580 (D.N.J.) Oct. 19, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 15-7584 (D.N.J.) Oct. 19, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Horizon Therapeutics, Inc. v. Lupin Ltd., 15-7624 (D.N.J.) Oct. 19, 2015 Hon. Robert B. Kugler Ravicti® (glycerol phenylbutyrate oral liquid)
8,404,215
8,642,012
9,095,559
Fresenius Kabi USA, LLC v. Mylan Labs. Ltd., 15-0185 (N.D.W.V.) Oct. 19, 2015 Hon. Irene M. Keeley Naropin® (ropivacaine hydrochloride for injection)
7,828,787
7,857,802
8,118,802
8,162,915
Alcon Pharms. Ltd. v. Akorn, Inc., 15-0948 (D. Del.) Oct. 21, 2015 Hon. Sue L. Robinson Vigamox® (moxifloxacin hydrochloride ophthalmic solution)
6,716,830
7,671,070
Takeda Pharm. Co. Ltd. v. Aurobindo Pharma Ltd., 15-7635 (D.N.J.) Oct. 21, 2015 Hon. Mary L. Cooper Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)
6,328,994
7,431,942
7,875,292
7,399,485
Pfizer Inc. v. Mylan Inc., 15-0960 (D. Del.) Oct. 22, 2015 Hon. Sue L. Robinson Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
8,975,242
Unimed Pharms., LLC v. Amneal Pharms., LLC, 15-0964 (D. Del.) Oct. 23, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Forest Labs., LLC v. Amerigen Pharms., Inc., 15-0966 (D. Del.) Oct. 23, 2015 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules)
8,039,009
8,058,291
8,168,209
8,173,708
8,283,379
8,293,794
8,329,752
8,338,485
8,338,486
8,362,085
8,580,858
8,598,233
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-0969 (D. Del.) Oct. 23, 2015 Hon. Gregory M. Sleet Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 9,040,083
Takeda Pharm. Co. Ltd. v. Aurobindo Pharma Ltd., 15-9398 (N.D. Ill.) Oct. 23, 2015 Hon. Charles P. Kocoras Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)
6,328,994
7,431,942
7,875,292
7,399,485
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-7684 (D.N.J.) Oct. 23, 2015 Hon. Claire C. Cecchi Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 9,040,083
Mallinckrodt LLC v. Par Pharm. Inc., 15-7694 (D.N.J.) Oct. 23, 2015 Hon. Katharine S. Hayden Xartemis XR® (oxycodone hydrochloride / acetaminophen extended-release tablets)
6,488,962
8,597,681
8,658,631
8,741,885
8,980,319
8,992,975
7,976,870
8,668,929
8,372,432
8,377,453
8,394,408
9,050,335
Pfizer Inc. v. Mylan Inc., 15-0188 (N.D.W.V.) Oct. 23, 2015 Hon. Irene M. Keeley Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
8,975,242
Novartis AG v. Apotex Inc., 15-0975 (D. Del.) Oct. 26, 2015 Hon. Leonard P. Stark Gilenya® (fingolimod capsules) 5,604,229
Par Pharm., Inc. v. Novartis AG, IPR2016-00074 (PTAB) Oct. 26, 2015 N/A Afinitor® (everolimus tablets) 7,741,338
Par Pharm., Inc. v. Novartis AG, IPR2016-00075 (PTAB) Oct. 26, 2015 N/A Afinitor® (everolimus tablets) 7,297,703
Par Pharm., Inc. v. Novartis AG, IPR2016-00078 (PTAB) Oct. 26, 2015 N/A Zortress® (everolimus tablets) 6,455,518
Par Pharm., Inc. v. Novartis AG, IPR2016-00084 (PTAB) Oct. 26, 2015 N/A Zortress® (everolimus tablets) 5,665,772
Complex Innovations, LLC v. Amgen Inc., IPR2016-00085 (PTAB) Oct. 26, 2015 N/A Sensipar® (cinacalcet hydrochloride tablets) 7,829,595
Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0979 (D. Del.) Oct. 27, 2015 Hon. Leonard P. Stark Daytrana® (methylphenidate transdermal system)
6,210,705
6,348,211
8,632,802
9,034,370
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 15-7742 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-7743 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Horizon Pharma Ireland Ltd. v. IGI Labs., Inc., 15-7744 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-7745 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Novartis Pharms. Corp. v. Amneal Pharms. LLC, 15-0986 (D. Del.) Oct. 28, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Novartis Pharms. Corp. v. Natco Pharma Ltd., 15-0987 (D. Del.) Oct. 28, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Novartis AG v. Apotex Inc., 15-62273 (S.D. Fla.) Oct. 28, 2015 Hon. Beth Bloom Gilenya® (fingolimod capsules) 5,604,229
Fresenius Kabi USA, LLC v. Cephalon, Inc., IPR2016-00098 (PTAB) Oct. 28, 2015 N/A Treanda® (bendamustine hydrochloride for infusion) 8,791,270
Novartis Pharms. Corp. v. Natco Pharma Ltd., 15-8534 (S.D.N.Y.) Oct. 29, 2015 Hon. Andrew L. Carter, Jr, Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0194 (N.D.W.V.) Oct. 29, 2015 Hon. Irene M. Keeley Daytrana® (methylphenidate transdermal system)
6,210,705
6,348,211
8,632,802
9,034,370
Orexo AB v. Actavis Elizabeth LLC, 15-0996 (D. Del.) Oct. 30, 2015 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride tablets)
8,454,996
8,940,330
AstraZeneca LP v. Mylan Inc., 15-0999 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Sigmapharm Labs., LLC, 15-1000 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. InvaGen Pharms. Inc., 15-1001 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Watson Labs., Inc., 15-1002 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
AstraZeneca LP v. Alembic Pharms. Ltd., 15-1003 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 15-7802 (D.N.J.) Oct. 30, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Otsuka Pharm. Co., Ltd. v. Amneal Pharms. LLC, 15-7803 (D.N.J.) Oct. 30, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
AstraZeneca LP v. InvaGen Pharms. Inc, 15-6282 (E.D.N.Y.) Nov. 2, 2015 Hon. Kiyo A. Matsumoto Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2016-00089 (PTAB) Nov. 2, 2015 N/A Prolensa® (bromfenac sodium ophthalmic solution) 8,754,131
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2016-00090 (PTAB) Nov. 2, 2015 N/A Prolensa® (bromfenac sodium ophthalmic solution) 8,871,813
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2016-00091 (PTAB) Nov. 2, 2015 N/A Prolensa® (bromfenac sodium ophthalmic solution) 8,927,606
Fresenius Kabi USA, LLC v. Cephalon, Inc., IPR2016-00111 (PTAB) Nov. 2, 2015 N/A Treanda® (bendamustine hydrochloride for infusion) 8,895,756
AstraZeneca LP v. Sigmapharm Labs., LLC, 15-5948 (E.D. Pa.) Nov. 2, 2015 Hon. Gerald A. McHugh Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Mylan In., LLC, 15-0202 (N.D.W.V.) Nov. 2, 2015 Hon. Irene M. Keeley Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
Purdue Pharma L.P. v. Actavis Labs. FL, Inc., 15-1008 (D. Del.) Nov. 3, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,056,052
9,060,940
9,084,816
9,095,614
Boehringer Ingelheim Pharma Gmbh & Co. KG v. Apotex Corp., 15-7880 (D.N.J.) Nov. 3, 2015 Hon. Mary L. Cooper Pradaxa® ER (dabigatran etexilate mesylate capsules) 6,087,380
AstraZeneca Pharms. LP v. Teva Pharms. USA, Inc., 15-7889 (D.N.J.) Nov. 3, 2015 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
AstraZeneca LP v. Sandoz Inc., 15-1012 (D. Del.) Nov. 4, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
AstraZeneca LP v. Micro Labs Ltd., 15-1013 (D. Del.) Nov. 4, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
Indivior Inc. v. Mylan Technologies Inc., 15-1016 (D. Del.) Nov. 4, 2015 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
Warner Chilcott Co., LLC v. Mylan Pharms. Inc., 15-7882 (D.N.J.) Nov. 4, 2015 Hon. Mary L. Cooper Minastrin® 24 Fe (ethinyl estradiol / norethindrone acetate / ferrous fumarate tablets) 6,667,050
Novartis Pharms. Corp. v. Amneal Pharms. LLC, 15-1025 (D. Del.) Nov. 5, 2015 Hon. Richard G. Andrews Exelon® Patch (rivastigmine transdermal system or extended release film)
6,316,023
6,335,031
Novartis Pharms. Corp. v. Dr. Reddy’s Labs, Ltd., 15-1026 (D. Del.) Nov. 5, 2015 Hon. Richard G. Andrews Exelon® Patch (rivastigmine transdermal system or extended release film)
6,316,023
6,335,031
Takeda Gmbh v. Micro Labs USA, Inc., 15-7921 (D.N.J.) Nov. 5, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
Dow Pharm. Sciences, Inc. v. Tolmar, Inc., 15-7971 (D.N.J.) Nov. 5, 2015 Hon. Stanley R. Chesler Acanya® (clindamycin phosphate / benzoyl peroxide gel)
8,288,434
8,663,699
Indivior Inc. v. Mylan Technologies Inc., 15-0209 (N.D.W.V.) Nov. 5, 2015 Hon. Irene M. Keeley Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
Dow Pharm. Sciences, Inc. v. Tolmar, Inc., 15-1030 (D. Del.) Nov. 6, 2015 Hon. Gregory M. Sleet Acanya® (clindamycin phosphate / benzoyl peroxide gel)
8,288,434
8,663,699
Allergan Sales, LLC v. Aurobindo Pharma Ltd., 15-1032 (D. Del.) Nov. 6, 2015 Hon. Leonard P. Stark Acular LS® (ketorolac tromethamine ophthalmic solution)
8,008,338
8,207,215
8,377,982
8,541,463
8,648,107
8,906,950
8,946,281
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-13783 (D. Mass.) Nov. 6, 2015 Hon. F. Dennis Saylor, IV
OxyContin® (oxycodone extended-release tablets) 
Xtampza ER™ (oxycodone extended-release capsules)
9,073,933
Novartis Pharms. Corp. v. Dr. Reddy’s Labs, Ltd., 15-7964 (D.N.J.) Nov. 6, 2015 Hon. Renee Marie Bumb Exelon® Patch (rivastigmine transdermal system or extended release film)
6,316,023
6,335,031
Allergan Sales, LLC v. Aurobindo Pharma Ltd., 15-1719 (E.D. Tex.) Nov. 6, 2015 Hon. Rodney Gilstrap Acular LS® (ketorolac tromethamine ophthalmic solution)
8,008,338
8,207,215
8,377,982
8,541,463
8,648,107
8,906,950
8,946,281
Warner Chilcott (US), LLC v. Mylan Pharms., Inc., 15-1740 (E.D. Tex.) Nov. 9, 2015 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Shire Pharm. Development Inc. v. Lupin Ltd., 15-3437 (D. Md.) Nov. 10, 2015 Hon. George Jarrod Hazel Lialda® (mesalamine delayed-release tablets) 6,773,720
Dexcel Pharma Technologies Ltd. v. Apotex Corp., 15-8010 (D.N.J.) Nov. 10, 2015 Hon. Susan D. Wigenton Omeprazole delayed-release tablets
9,023,391
7,255,878
Dexcel Pharma Technologies Ltd. v. Sun Pharma Global FZE, 15-8017 (D.N.J.) Nov. 11, 2015 Hon. Susan D. Wigenton Omeprazole delayed-release tablets
9,023,391
7,255,878
Par Pharm., Inc. v. Breckenridge Pharm., Inc., 15-1039 (D. Del.) Nov. 11, 2015 Hon. Sue L. Robinson Megace® ES (megestrol acetate oral suspension)
9,101,540
9,101,549
9,107,827
AstraZeneca LP v. HEC Pharm Co., Ltd., 15-1041 (D. Del.) Nov. 12, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
7,265,124
8,425,934
AstraZeneca LP v. Hisun Pharm. (Hangzhou) Co., Ltd., 15-1042 (D. Del.) Nov. 12, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
Cephalon, Inc. v. Aurobindo Pharma Ltd., 15-1044 (D. Del.) Nov. 12, 2015 Hon. Gregory M. Sleet Nuvigil® (armodafinil tablets) 7,132,570
Shire Development LLC v. Apotex, Inc., 15-1045 (D. Del.) Nov. 12, 2015 Hon. Leonard P. Stark Fosrenol® (lanthanum carbonate tablets)
5,968,976
7,381,428
7,465,465
Dexcel Pharma Technologies Ltd. v. Dr. Reddy’s Labs., Ltd., 15-8042 (D.N.J.) Nov. 12, 2015 Hon. Susan D. Wigenton Omeprazole delayed-release tablets
9,023,391
7,255,878
Graybar Pharms., LLC v. Pozen, Inc., IPR2016-00191 (PTAB) Nov. 12, 2015 N/A Treximet® (naproxen sodium / sumatriptan succinate tablets) 7,332,183
Cosmo Technologies Ltd. v. Actavis Labs. FL, Inc., 15-1046 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Cosmo Technologies Ltd. v. Alvogen Pine Brook, LLC, 15-1047 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Cosmo Technologies Ltd. v. Lupin Ltd., 15-1048 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Cosmo Technologies Ltd. v. Par Pharm., Inc., 15-1049 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Novartis Pharms. Corp. v. Par Pharm., Inc., 15-1050 (D. Del.) Nov. 13, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 8,436,010
Indivior Inc. v. Sandoz Inc., 15-1051 (D. Del.) Nov. 13, 2015 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
AstraZeneca LP v. HEC Pharm Co., Ltd., 15-8082 (D.N.J..) Nov. 13, 2015 Hon. Peter G. Sheridan Brilinta® (ticagrelor tablets)
7,265,124
8,425,934
AstraZeneca LP v. Amneal Pharms. LLC, 15-1056 (D. Del.) Nov. 16, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Prinston Pharm. Inc., 15-1057 (D. Del.) Nov. 16, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Apotex Inc., 15-1058 (D. Del.) Nov. 16, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,525,060
7,250,419
7,265,124
8,425,934
Merck, Sharp & Dohme Corp. v. Hetero USA Inc., 15-8099 (D.N.J.) Nov. 16, 2015 Hon. Claire C. Cecchi Sustiva® (efavirenz tablets)
6,639,071
6,939,964
Osi Pharms., LLC v. Breckenridge Pharm., Inc., 15-1063 (D. Del.) Nov. 17, 2015 Hon. Sue L. Robinson Tarceva® (erlotinib hydrochloride tablets)
RE41,065
6,900,221
Helsinn Healthcare S.A. v. Qilu Pharm. Co., Ltd., 15-8132 (D.N.J.) Nov. 17, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,729,094
9,066,980
9,173,942
Pfizer Inc. v. Dr. Reddy’s Labs., Ltd., 15-1067 (D. Del.) Nov. 18, 2015 Hon. Gregory M. Sleet Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
Vanda Pharms. Inc. v. Lupin Ltd., 15-1073 (D. Del.) Nov. 19, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets)
8,586,610
9,138,432
Cephalon, Inc. v. Fresenius Kabi USA, LLC, 15-1074 (D. Del.) Nov. 19, 2015 Hon. Sue L. Robinson Trisenox® (arsenic trioxide injection)
6,723,351
6,855,339
6,861,076
6,884,439
Valeant Pharms. Int’l, Inc. v. Mylan Pharms., Inc., 15-8180 (D.N.J.) Nov. 19, 2015 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide injection)
8,247,425
8,420,663
8,552,025
8,822,490
Pfizer Inc. v. Dr. Reddy’s Labs., Ltd., 15-8226 (D.N.J.) Nov. 19, 2015 Hon. Renee Marie Bumb Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
AstraZeneca AB v. Dr. Reddy’s Labs., Inc., 15-8267 (D.N.J.) Nov. 19, 2015 Hon. Mary L. Cooper Nexium 24HR® (esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
Mylan Pharms. Inc. v. Baxter Int’l Inc., IPR2016-00217 (PTAB) Nov. 19, 2015 N/A Brevibloc® (esmolol hydrochloride injection) 6,310,094
Mylan Pharms. Inc. v. Baxter Int’l Inc., IPR2016-00218 (PTAB) Nov. 19, 2015 N/A Brevibloc® (esmolol hydrochloride injection) 6,528,540
Purdue Pharma L.P. v. Alvogen Pine Brook LLC, 15-1077 (D. Del.) Nov. 20, 2015 Hon. Sue L. Robinson Butrans® (buprenorphine transdermal system)
RE41,408
RE41,489
RE41,571
Shire LLC v. Abhai, LLC, 15- (D. Mass.) Nov. 20, 2015 Hon. William G. Young Adderall XR® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules)
RE42,096
RE41,148
Forest Labs., LLC v. InvaGen Pharms. Inc., 15-1078 (D. Del.) Nov. 23, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone hydrochloride tablets)
7,834,020
8,193,195
8,236,804
8,673,921
Jazz Pharms., Inc. v. Sun Pharm. Indus. Ltd., 15-8229 (D.N.J.) Nov. 23, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Argentum Pharms. LLC v. Research Corp. Technologies, Inc., IPR2016-00204 (PTAB) Nov. 23, 2015 N/A Vimpat® (lacosamide) RE38,551
Horizon Pharma, Inc. v. Actavis Labs. Fl., Inc. 15-8523 (D.N.J.) Nov. 24, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
6,926,907
8,557,285
Horizon Pharma, Inc. v. Actavis Labs. Fl., Inc. 15-8524 (D.N.J.) Nov. 24, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,852,636
8,858,996
8,865,190
Neptune Generics, LLC v. Eli Lilly & Co., IPR2016-00237 (PTAB) Nov. 24, 2015 N/A Alimta® (pemetrexed disodium injection) 7,772,209
Neptune Generics, LLC v. Eli Lilly & Co., IPR2016-00240 (PTAB) Nov. 24, 2015 N/A Alimta® (pemetrexed disodium injection) 7,772,209
J. Kyle Bass v. Alpex Pharma., IPR2016-00245 (PTAB) Nov. 24, 2015 N/A Suprenza® (phentermine hydrochloride tablets) 8,440,170
Symed Labs Ltd. v. Roxane Labs., Inc., 15-8304 (D.N.J.) Nov. 25, 2015 Hon. Claire C. Cecchi Form III Linezolid (linezolid oral suspension)
7,714,128
7,732,597
7,718,800
7,718,799
Otsuka Pharm. Co., Ltd. v. Alkem Labs. Ltd., 15-8305 (D.N.J.) Nov. 25, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
Symed Labs Ltd. v. Glenmark Pharms. Inc., USA, 15-8306 (D.N.J.) Nov. 25, 2015 Hon. Claire C. Cecchi Form III Linezolid (linezolid oral suspension)
7,714,128
7,732,597
Symed Labs Ltd. v. Amneal Pharms. LLC, 15-8307 (D.N.J.) Nov. 25, 2015 Hon. Claire C. Cecchi Form III Linezolid (linezolid oral suspension)
7,714,128
7,732,597
7,718,800
7,718,799
Supernus Pharms., Inc. v. Actavis Inc., 15-8342 (D.N.J.) Nov. 25, 2015 Hon. Renee Marie Bumb Oxtellar XR® (oxcarbazepine extended-release tablets) 9,119,791
J. Kyle Bass v. Fresenius Kabi USA, LLC, IPR2016-00254 (PTAB) Nov. 25, 2015 N/A Diprivan® (propofol injection) 8,476,010
Shire Orphan Therapies LLC v. Fresenius Kabi USA, LLC, 15-1102 (D. Del.) Nov. 30, 2015 Hon. Gregory M. Sleet Firazyr® (icatibant acetate) 5,648,333
Novartis Pharms. Corp. v. Shilpa Medicare Ltd., 15-1111 (D. Del.) Nov. 30, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Valeant Pharms. Int’l, Inc. v. Actavis LLC, 15-8353 (D.N.J.) Nov. 30, 2015 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide injection)
8,247,425
8,420,663
8,552,025
8,822,490
Helsinn Healthcare S.A. v. Qilu Pharm. Co., Ltd., 15-6392 (E.D. Pa.) Dec. 1, 2015 Hon. Cynthia M. Rufe Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,729,094
9,066,980
9,173,942
Unimed Pharms., LLC v. Sandoz Inc., 15-1120 (D. Del.) Dec. 3, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,466,136
8,466,137
8,466,138
8,486,925
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Teva Pharms. USA, Inc. v. RB Pharms. Ltd., IPR2016-00280 (PTAB) Dec. 3, 2015 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,475,832
Teva Pharms. USA, Inc. v. MonSol Rx, LLC, IPR2016-00281 (PTAB) Dec. 3, 2015 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,603,514
Teva Pharms. USA, Inc. v. MonoSol RX, LLC, IPR2016-00282 (PTAB) Dec. 3, 2015 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,017,150
UCB, Inc. v. InvaGen Pharms., Inc., 15-6919 (E.D.N.Y.) Dec. 4, 2015 Hon. Kiyo A. Matsumoto Zyrtec-D® (cetirizine hydrochloride / pseudoephedrine hydrochloride tablets)
6,469,009
7,014,867
7,226,614
Galderma Labs., L.P. v. Teligent, Inc., 15-3876 (N.D. Tex.) Dec. 4, 2015 Hon. David C. Godbey Clobex® (clobetasol propionate topical solution) 6,106,848
Lupin Ltd. v. Horizon Therapeutics, Inc., IPR2016-00283 (PTAB) Dec. 4, 2015 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 8,642,012
Lupin Ltd. v. Horizon Therapeutics, Inc., IPR2016-00284 (PTAB) Dec. 4, 2015 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 8,404,215
Amerigen Pharms. Ltd. v. Janssen Oncology, Inc, IPR2016-00286 (PTAB) Dec. 4, 2015 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Takeda Gmbh v. Apotex Corp., 15-8492 (D.N.J.) Dec. 7, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
AstraZeneca Pharms. LP v. Amneal Pharms. LLC, 15-1139 (D. Del.) Dec. 9, 2015 Hon. Gregory M. Sleet Byetta® (exenatide injection)
6,872,700
6,902,744
Unimed Pharms., LLC v. Dr. Reddy’s Labs., Ltd., 15-1142 (D. Del.) Dec. 10, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,466,136
8,466,137
8,466,138
8,486,925
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Celgene Corp. v. Teva Pharms. USA, Inc., 15-1143 (D. Del.) Dec. 10, 2015 Hon. Richard G. Andrews Istodax® (romidepsin injection)
7,608,280
7,611,724
Aptalis Pharma US, Inc. v. Pharm. Sourcing Partners, Inc., 15-8637 (D.N.J.) Dec. 14, 2015 Hon. Mary L. Cooper Canasa® (mesalamine rectal suppositories)
7,541,384
8,217,083
8,436,051
Sandoz Inc. v. Eli Lilly & Co., IPR2016-00318 (PTAB) Dec. 14, 2015 N/A Alimta® (pemetrexed disodium injection) 7,772,209
Purdue Pharma L.P. v. Amneal Pharms. LLC, 15-1152 (D. Del.) Dec. 15, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone extended-release tablets)
7,674,799
7,674,800
7,683,072
8,114,383
8,309,060
8,337,888
8,808,741
8,894,987
8,894,988
9,060,976
9,034,376
9,073,933
Helsinn Healthcare S.A. v. Dr. Reddy’s Labs., Ltd., 15-8662 (D.N.J.) Dec. 15, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection) 9,173,942
Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., 15-8663 (D.N.J.) Dec. 15, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection) 9,173,942
Purdue Pharma L.P. v. Mylan Pharms. Inc., 15-1155 (D. Del.) Dec. 16, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone extended-release tablets) 9,073,933
Alcon Research Ltd. v. Watson Labs., Inc., 15-1159 (D. Del.) Dec. 16, 2015 Hon. Sue L. Robinson Pazeo® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00348 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 7,297,761
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00353 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 7,691,963
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00354 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 8,445,647
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00355 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 8,951,962
Shire Orphan Therapies LLC v. Sandoz Inc., 15-1161 (D. Del.) Dec. 17, 2015 Hon. Gregory M. Sleet Firazyr® (icatibant acetate) 5,648,333
Bayer Healthcare LLC v. Mylan Pharms. Inc., 15-1162 (D. Del.) Dec. 17, 2015 Hon. Leonard P. Stark Nexavar® (sorafenib tosylate tablets)
7,897,623
7,235,576
7,351,834
8,877,933
8,841,330
Cubist Pharms. LLC v. Sagent Pharms., Inc., 15-1164 (D. Del.) Dec. 17, 2015 Hon. Gregory M. Sleet Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Purdue Pharma L.P. v. Mylan Pharms. Inc., 15-0232 (D. Del.) Dec. 17, 2015 Hon. Irene M. Keeley OxyContin® (oxycodone extended-release tablets) 9,073,933
Forest Labs., LLC v. Panacea Biotec, Ltd., 15-1171 (D. Del.) Dec. 18, 2015 Hon. Leonard P. Stark Namenda® XR (memantine hydrochloride extended-release tablets)
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233
Lower Drug Prices for Consumers, LLC v. Forest Labs. Holdings, Ltd., IPR2016-00379 (PTAB) Dec. 22, 2015 N/A Bystolic® (nebivolol hydrochloride tablets) 6,545,040
Recro Gainesville LLC v. Actavis Labs. FL, Inc., 15-1196 (D. Del.) Dec. 23, 2015 Hon. Gregory M. Sleet Zohydro® ER (hydrocodone bitartrate extended-release capsules) 9,132,096
Sanofi v. Alkem Labs. Ltd., 15-1200 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. First Time US Generics LLC, 15-1205 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Glenmark Pharms. Inc. USA, 15-1206 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Sandoz Inc., 15-1207 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Sun Pharma Global FZE, 15-1208 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Watson Labs., Inc., 15-1209 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Otsuka Pharm. Co., Ltd. v. Ajanta Pharma Ltd., 15-8830 (D.N.J.) Dec. 23, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Aptalis Pharma US, Inc. v. Delcor Asset Corp., 15-8919 (D.N.J.) Dec. 23, 2015 Hon. Mary L. Cooper Canasa® (mesalamine rectal suppositories)
7,541,384
8,217,083
8,436,051
Aptalis Pharma US, Inc. v. Delcor Asset Corp., 15-1210 (D. Del.) Dec. 27, 2015 Hon. Leonard P. Stark Canasa® (mesalamine rectal suppositories)
7,541,384
8,217,083
8,436,051
Lupin Ltd. v. iCeutica Pty Ltd., IPR2016-00397 (PTAB) Dec. 28, 2015 N/A Zorvolex® (diclofenac tablets) 8,999,387
Lupin Ltd. v. iCeutica Pty Ltd., IPR2016-00399 (PTAB) Dec. 28, 2015 N/A Zorvolex® (diclofenac tablets) 9,017,721
Cubist Pharms. LLC v. Actavis LLC, 15-1214 (D. Del.) Dec. 29, 2015 Hon. Gregory M. Sleet Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Novartis Pharms. Corp. v. Actavis, Inc., 15-1219 (D. Del.) Dec. 30, 2015 Hon. Richard G. Andrews Jadenu® (deferasirox tablets) 6,465,504
Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 15-8955 (D.N.J.) Dec. 30, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Novartis Pharms. Corp. v. Actavis, Inc., 15-8978 (D.N.J.) Dec. 31, 2015 Hon. Jose L. Linares Jadenu® (deferasirox tablets) 6,465,504
Merz Pharms., LLC v. Taro Pharms. U.S.A., Inc., 15-10168 (S.D.N.Y.) Dec. 31, 2015 Hon. William H. Pauley, III Naftin® (naftifine hydrochloride gel) 9,161,914

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.